(2R)-3-[[6-(2-amino-2-oxoethyl)-15-(3-amino-3-oxopropyl)-12-[(4-bromophenyl)methyl]-9-(1-hydroxyethyl)-7,16,19-trimethyl-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]amino]-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-3-(4-bromophenyl)-2-[[(2S)-2-formamidopropanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3,3-dimethylpentanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-oxopropane-1-sulfonic acid
| Internal ID | 461df5a7-96f6-4969-b9a7-ba0b40948385 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | (2R)-3-[[6-(2-amino-2-oxoethyl)-15-(3-amino-3-oxopropyl)-12-[(4-bromophenyl)methyl]-9-(1-hydroxyethyl)-7,16,19-trimethyl-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]amino]-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-3-(4-bromophenyl)-2-[[(2S)-2-formamidopropanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3,3-dimethylpentanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-oxopropane-1-sulfonic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C80H124Br2N20O16S/c1-11-80(7,8)70(99-75(111)66-19-15-32-102(66)78(114)62(95-71(107)47(4)92-45-103)35-51-22-26-54(82)27-23-51)77(113)98-69(46(2)3)76(112)94-61(36-52-38-90-59-17-13-12-16-58(52)59)73(109)93-60(18-14-30-88-79(85)86)72(108)97-65(44-119(115,116)117)74(110)96-64-43-100(9)56(28-29-67(83)105)41-89-55(34-50-20-24-53(81)25-21-50)39-91-63(48(5)104)42-101(10)57(37-68(84)106)40-87-31-33-118-49(64)6/h12-13,16-17,20-27,38,45-49,55-57,60-66,69-70,87,89-91,104H,11,14-15,18-19,28-37,39-44H2,1-10H3,(H2,83,105)(H2,84,106)(H,92,103)(H,93,109)(H,94,112)(H,95,107)(H,96,110)(H,97,108)(H,98,113)(H,99,111)(H4,85,86,88)(H,115,116,117)/t47-,48?,49?,55?,56?,57?,60-,61-,62-,63?,64?,65-,66-,69-,70+/m0/s1 |
| InChI Key | LTDGOWOVLPGYRM-JSSNSWOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C80H124Br2N20O16S |
| Molecular Weight | 1813.80 g/mol |
| Exact Mass | 1812.75711 g/mol |
| Topological Polar Surface Area (TPSA) | 554.00 Ų |
| XlogP | -0.80 |
| Atomic LogP (AlogP) | -0.68 |
| H-Bond Acceptor | 21 |
| H-Bond Donor | 18 |
| Rotatable Bonds | 38 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9076 | 90.76% |
| Caco-2 | - | 0.8612 | 86.12% |
| Blood Brain Barrier | - | 0.6750 | 67.50% |
| Human oral bioavailability | - | 0.6857 | 68.57% |
| Subcellular localzation | Lysosomes | 0.4852 | 48.52% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8038 | 80.38% |
| OATP1B3 inhibitior | + | 0.9318 | 93.18% |
| MATE1 inhibitior | - | 0.7009 | 70.09% |
| OCT2 inhibitior | - | 0.5500 | 55.00% |
| BSEP inhibitior | + | 0.9734 | 97.34% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.8728 | 87.28% |
| CYP3A4 substrate | + | 0.7680 | 76.80% |
| CYP2C9 substrate | - | 0.7845 | 78.45% |
| CYP2D6 substrate | - | 0.7738 | 77.38% |
| CYP3A4 inhibition | + | 0.6819 | 68.19% |
| CYP2C9 inhibition | - | 0.6819 | 68.19% |
| CYP2C19 inhibition | - | 0.6481 | 64.81% |
| CYP2D6 inhibition | - | 0.8355 | 83.55% |
| CYP1A2 inhibition | - | 0.6816 | 68.16% |
| CYP2C8 inhibition | + | 0.8615 | 86.15% |
| CYP inhibitory promiscuity | - | 0.8107 | 81.07% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | + | 0.5300 | 53.00% |
| Carcinogenicity (trinary) | Non-required | 0.5677 | 56.77% |
| Eye corrosion | - | 0.9754 | 97.54% |
| Eye irritation | - | 0.8953 | 89.53% |
| Skin irritation | - | 0.7560 | 75.60% |
| Skin corrosion | - | 0.9083 | 90.83% |
| Ames mutagenesis | - | 0.6600 | 66.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7131 | 71.31% |
| Micronuclear | + | 0.8200 | 82.00% |
| Hepatotoxicity | - | 0.5600 | 56.00% |
| skin sensitisation | - | 0.8219 | 82.19% |
| Respiratory toxicity | + | 0.8444 | 84.44% |
| Reproductive toxicity | + | 0.8778 | 87.78% |
| Mitochondrial toxicity | + | 0.5750 | 57.50% |
| Nephrotoxicity | - | 0.9600 | 96.00% |
| Acute Oral Toxicity (c) | III | 0.5638 | 56.38% |
| Estrogen receptor binding | - | 0.5630 | 56.30% |
| Androgen receptor binding | + | 0.7429 | 74.29% |
| Thyroid receptor binding | + | 0.8198 | 81.98% |
| Glucocorticoid receptor binding | + | 0.8526 | 85.26% |
| Aromatase binding | + | 0.8265 | 82.65% |
| PPAR gamma | + | 0.7873 | 78.73% |
| Honey bee toxicity | - | 0.6051 | 60.51% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | + | 0.5100 | 51.00% |
| Fish aquatic toxicity | + | 0.9771 | 97.71% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.91% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.88% | 96.61% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.61% | 98.33% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 99.55% | 96.31% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.51% | 97.64% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.23% | 96.09% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 99.16% | 97.09% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 99.10% | 95.38% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 98.92% | 95.56% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 98.73% | 85.31% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 98.44% | 95.52% |
| CHEMBL4644 | P41968 | Melanocortin receptor 3 | 98.27% | 99.52% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 97.81% | 92.12% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 97.80% | 91.81% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.76% | 91.11% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 97.54% | 97.25% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 96.98% | 98.24% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 96.84% | 88.42% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 96.22% | 93.10% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.91% | 94.66% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 95.81% | 100.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 95.47% | 90.08% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.32% | 100.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 95.27% | 95.89% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 95.02% | 96.67% |
| CHEMBL4801 | P29466 | Caspase-1 | 94.99% | 96.85% |
| CHEMBL4072 | P07858 | Cathepsin B | 94.79% | 93.67% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 94.21% | 89.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 94.12% | 94.45% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 94.10% | 96.25% |
| CHEMBL4393 | P39900 | Matrix metalloproteinase 12 | 93.93% | 92.22% |
| CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 93.23% | 95.34% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 92.90% | 99.18% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 92.44% | 92.88% |
| CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 92.43% | 97.56% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 92.23% | 95.00% |
| CHEMBL1907599 | P05556 | Integrin alpha-4/beta-1 | 92.15% | 92.86% |
| CHEMBL4608 | P33032 | Melanocortin receptor 5 | 92.13% | 97.00% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 91.98% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 91.43% | 97.14% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.05% | 96.47% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 91.00% | 97.23% |
| CHEMBL2327 | P21452 | Neurokinin 2 receptor | 90.92% | 98.89% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 90.72% | 92.38% |
| CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator | 90.55% | 95.71% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 90.14% | 96.28% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 90.11% | 93.56% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 90.10% | 100.00% |
| CHEMBL2535 | P11166 | Glucose transporter | 90.03% | 98.75% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 89.80% | 82.38% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 89.14% | 97.50% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 88.67% | 96.67% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 88.36% | 99.17% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 88.19% | 95.00% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 88.17% | 95.92% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 86.94% | 98.05% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 86.71% | 96.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 86.66% | 96.90% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 86.45% | 88.56% |
| CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 86.39% | 97.31% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 86.28% | 98.59% |
| CHEMBL3729 | P22748 | Carbonic anhydrase IV | 86.01% | 99.23% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 85.86% | 93.00% |
| CHEMBL222 | P23975 | Norepinephrine transporter | 85.83% | 96.06% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 84.72% | 95.17% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 84.42% | 88.10% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 84.41% | 94.00% |
| CHEMBL5028 | O14672 | ADAM10 | 84.17% | 97.50% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 84.08% | 100.00% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 84.00% | 93.99% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 83.35% | 90.71% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 83.24% | 89.63% |
| CHEMBL3230 | O95977 | Sphingosine 1-phosphate receptor Edg-6 | 82.52% | 94.01% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.46% | 95.50% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 82.26% | 93.03% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 82.13% | 82.50% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 81.97% | 90.95% |
| CHEMBL238 | Q01959 | Dopamine transporter | 81.47% | 95.88% |
| CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 81.30% | 96.69% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 102086573 |
| LOTUS | LTS0065322 |
| wikiData | Q105156891 |